DexCom (DXCM) Competitors $74.40 -0.94 (-1.25%) As of 03:15 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DXCM vs. HQY, PODD, ABT, AMN, ITGR, MDT, BDX, IDXX, EW, and RMDShould you be buying DexCom stock or one of its competitors? The main competitors of DexCom include HealthEquity (HQY), Insulet (PODD), Abbott Laboratories (ABT), AMN Healthcare Services (AMN), Integer (ITGR), Medtronic (MDT), Becton, Dickinson and Company (BDX), IDEXX Laboratories (IDXX), Edwards Lifesciences (EW), and ResMed (RMD). These companies are all part of the "medical" sector. DexCom vs. Its Competitors HealthEquity Insulet Abbott Laboratories AMN Healthcare Services Integer Medtronic Becton, Dickinson and Company IDEXX Laboratories Edwards Lifesciences ResMed HealthEquity (NASDAQ:HQY) and DexCom (NASDAQ:DXCM) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation, media sentiment and analyst recommendations. Do insiders & institutionals hold more shares of HQY or DXCM? 99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 1.5% of HealthEquity shares are owned by insiders. Comparatively, 0.3% of DexCom shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more volatility and risk, HQY or DXCM? HealthEquity has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500. Comparatively, DexCom has a beta of 1.48, indicating that its stock price is 48% more volatile than the S&P 500. Does the media prefer HQY or DXCM? In the previous week, HealthEquity and HealthEquity both had 26 articles in the media. DexCom's average media sentiment score of 1.31 beat HealthEquity's score of 1.11 indicating that DexCom is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 14 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive DexCom 22 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation and earnings, HQY or DXCM? DexCom has higher revenue and earnings than HealthEquity. DexCom is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHealthEquity$1.20B6.42$96.70M$1.3765.06DexCom$4.03B7.22$576.20M$1.4451.56 Is HQY or DXCM more profitable? DexCom has a net margin of 13.29% compared to HealthEquity's net margin of 9.80%. DexCom's return on equity of 30.41% beat HealthEquity's return on equity.Company Net Margins Return on Equity Return on Assets HealthEquity9.80% 11.01% 6.77% DexCom 13.29%30.41%10.08% Do analysts prefer HQY or DXCM? HealthEquity presently has a consensus target price of $117.82, suggesting a potential upside of 32.18%. DexCom has a consensus target price of $99.89, suggesting a potential upside of 34.54%. Given DexCom's higher possible upside, analysts plainly believe DexCom is more favorable than HealthEquity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HealthEquity 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.00DexCom 0 Sell rating(s) 4 Hold rating(s) 15 Buy rating(s) 3 Strong Buy rating(s) 2.95 SummaryDexCom beats HealthEquity on 12 of the 16 factors compared between the two stocks. Get DexCom News Delivered to You Automatically Sign up to receive the latest news and ratings for DXCM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DXCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DXCM vs. The Competition Export to ExcelMetricDexComMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$29.09B$6.73B$5.68B$9.65BDividend YieldN/A1.19%6.66%4.53%P/E Ratio51.5125.4082.7326.36Price / Sales7.2270.96536.75111.24Price / Cash33.5222.4425.6628.92Price / Book13.804.8911.306.04Net Income$576.20M$174.79M$3.27B$265.75M7 Day Performance-2.46%-0.24%0.01%-0.35%1 Month Performance-6.34%3.67%8.17%5.54%1 Year Performance7.08%6.96%54.17%17.46% DexCom Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DXCMDexCom4.9765 of 5 stars$74.40-1.2%$99.89+34.3%+8.7%$29.16B$4.03B51.6310,300Positive NewsHQYHealthEquity4.2412 of 5 stars$87.42-2.7%$118.55+35.6%+12.3%$7.56B$1.20B63.813,120Positive NewsPODDInsulet4.2998 of 5 stars$329.00-0.5%$332.71+1.1%+67.6%$23.16B$2.07B100.003,900Positive NewsABTAbbott Laboratories4.9696 of 5 stars$132.02-0.4%$144.47+9.4%+17.1%$229.78B$41.95B16.54114,000Positive NewsAMNAMN Healthcare Services4.3548 of 5 stars$20.69-0.3%$28.25+36.5%-60.8%$792.84M$2.98B-2.662,968Positive NewsITGRInteger4.2802 of 5 stars$108.98-1.4%$140.25+28.7%-17.3%$3.82B$1.79B48.0111,000News CoveragePositive NewsAnalyst UpgradeMDTMedtronic4.6867 of 5 stars$92.02-0.7%$101.15+9.9%+4.7%$117.95B$33.54B25.3595,000Positive NewsAnalyst UpgradeBDXBecton, Dickinson and Company4.7726 of 5 stars$194.70-2.5%$211.44+8.6%-20.4%$55.81B$20.18B35.0274,000Positive NewsIDXXIDEXX Laboratories4.503 of 5 stars$641.35-0.7%$649.44+1.3%+34.4%$51.31B$3.90B53.4011,000Positive NewsShort Interest ↓EWEdwards Lifesciences4.3208 of 5 stars$80.92-1.1%$85.90+6.2%+16.5%$47.51B$5.69B11.6415,800Positive NewsAnalyst UpgradeRMDResMed4.7324 of 5 stars$285.76-2.7%$274.83-3.8%+12.1%$41.84B$5.15B30.0510,600Positive NewsAnalyst Upgrade Related Companies and Tools Related Companies HealthEquity Competitors Insulet Competitors Abbott Laboratories Competitors AMN Healthcare Services Competitors Integer Competitors Medtronic Competitors Becton, Dickinson and Company Competitors IDEXX Laboratories Competitors Edwards Lifesciences Competitors ResMed Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DXCM) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersYou'll Want to See Who's Backing This Penny Stock Gold ProducerWhy Are Famous Billionaires Buying This Gold Miner? Gold legends-Eric Sprott, Goldcorp founder Rob McEwen, ...i2i Marketing Group, LLC | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DexCom, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DexCom With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DXCM Stock Alerts